 | • レポートコード：MRC2312MG08632 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、65ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の医薬品用発酵エンジニアリング市場規模と予測を収録しています。・世界の医薬品用発酵エンジニアリング市場：売上、2018年-2023年、2024年-2029年 ・世界の医薬品用発酵エンジニアリング市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の医薬品用発酵エンジニアリング市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「モノクローナル抗体」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 医薬品用発酵エンジニアリングのグローバル主要企業は、Changchun GeneScience Pharmaceutical、 3SBio Inc、 Shanghai Fosun Pharmaceutical、 Sichuan Kelun Pharmaceutical、 Shanghai Shyndec Pharmaceutical、 CSPC Pharmaceutical Group、 United Laboratories International Holdings、 Tonghua Dongbao Pharmaceutical、 Joincare Pharmaceutical Group、 North China Pharma、 Anhui Anke Biotechnology、 Gan and Lee Pharmaceuticals、 Shandong Kexing Bioproducts、 Harbin Pharmaceutical Groupなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、医薬品用発酵エンジニアリングのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の医薬品用発酵エンジニアリング市場：タイプ別、2018年-2023年、2024年-2029年 世界の医薬品用発酵エンジニアリング市場：タイプ別市場シェア、2022年 ・モノクローナル抗体、抗生物質、インスリン、ヒト成長ホルモン、医薬品アミノ酸、その他 世界の医薬品用発酵エンジニアリング市場：用途別、2018年-2023年、2024年-2029年 世界の医薬品用発酵エンジニアリング市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界の医薬品用発酵エンジニアリング市場：地域・国別、2018年-2023年、2024年-2029年 世界の医薬品用発酵エンジニアリング市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における医薬品用発酵エンジニアリングのグローバル売上、2018年-2023年 ・主要企業における医薬品用発酵エンジニアリングのグローバル売上シェア、2022年 ・主要企業における医薬品用発酵エンジニアリングのグローバル販売量、2018年-2023年 ・主要企業における医薬品用発酵エンジニアリングのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Changchun GeneScience Pharmaceutical、 3SBio Inc、 Shanghai Fosun Pharmaceutical、 Sichuan Kelun Pharmaceutical、 Shanghai Shyndec Pharmaceutical、 CSPC Pharmaceutical Group、 United Laboratories International Holdings、 Tonghua Dongbao Pharmaceutical、 Joincare Pharmaceutical Group、 North China Pharma、 Anhui Anke Biotechnology、 Gan and Lee Pharmaceuticals、 Shandong Kexing Bioproducts、 Harbin Pharmaceutical Group ************************************************************* ・調査・分析レポートの概要 医薬品用発酵エンジニアリング市場の定義 市場セグメント 世界の医薬品用発酵エンジニアリング市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の医薬品用発酵エンジニアリング市場規模 世界の医薬品用発酵エンジニアリング市場規模：2022年 VS 2029年 世界の医薬品用発酵エンジニアリング市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの医薬品用発酵エンジニアリングの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の医薬品用発酵エンジニアリング製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：モノクローナル抗体、抗生物質、インスリン、ヒト成長ホルモン、医薬品アミノ酸、その他 医薬品用発酵エンジニアリングのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 医薬品用発酵エンジニアリングの用途別グローバル売上・予測 ・地域別市場分析 地域別医薬品用発酵エンジニアリング市場規模 2022年と2029年 地域別医薬品用発酵エンジニアリング売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Changchun GeneScience Pharmaceutical、 3SBio Inc、 Shanghai Fosun Pharmaceutical、 Sichuan Kelun Pharmaceutical、 Shanghai Shyndec Pharmaceutical、 CSPC Pharmaceutical Group、 United Laboratories International Holdings、 Tonghua Dongbao Pharmaceutical、 Joincare Pharmaceutical Group、 North China Pharma、 Anhui Anke Biotechnology、 Gan and Lee Pharmaceuticals、 Shandong Kexing Bioproducts、 Harbin Pharmaceutical Group ... |
This research report provides a comprehensive analysis of the Fermentation Engineering for Pharmaceutical Drugs market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Fermentation Engineering for Pharmaceutical Drugs market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Fermentation Engineering for Pharmaceutical Drugs, challenges faced by the industry, and potential opportunities for market players.
The global Fermentation Engineering for Pharmaceutical Drugs market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Fermentation Engineering for Pharmaceutical Drugs market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Fermentation Engineering for Pharmaceutical Drugs market. Additionally, the growing consumer demand present avenues for market expansion.
The global Fermentation Engineering for Pharmaceutical Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In China, 5 largest manufacturers of Fermentation Engineering for Pharmaceutical Drugs are Changchun GeneScience Pharmaceutical, 3SBio Inc, Shanghai Fosun Pharmaceutical, Sichuan Kelun Pharmaceutical and Shanghai Shyndec Pharmaceutical, which make up over 15%. Among them, Changchun GeneScience Pharmaceutical is the leader with about 6% market share. In terms of product type, Monoclonal Antibodies occupy the largest share of the total market, about 54%. And in terms of product Application, the largest application is Hospital, followed by Clinic.
Key Features:
The research report on the Fermentation Engineering for Pharmaceutical Drugs market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Fermentation Engineering for Pharmaceutical Drugs market.
Market Overview: The report provides a comprehensive overview of the Fermentation Engineering for Pharmaceutical Drugs market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Monoclonal Antibodies, Antibiotic), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Fermentation Engineering for Pharmaceutical Drugs market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Fermentation Engineering for Pharmaceutical Drugs market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Fermentation Engineering for Pharmaceutical Drugs market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Fermentation Engineering for Pharmaceutical Drugs market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Fermentation Engineering for Pharmaceutical Drugs market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Fermentation Engineering for Pharmaceutical Drugs market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Fermentation Engineering for Pharmaceutical Drugs, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Fermentation Engineering for Pharmaceutical Drugs market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Fermentation Engineering for Pharmaceutical Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Monoclonal Antibodies
Antibiotic
Insulin
Human Growth Hormone
Pharmaceutical Amino Acids
Others
Market segment by Application
Hospital
Clinic
Other
Global Fermentation Engineering for Pharmaceutical Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Changchun GeneScience Pharmaceutical
3SBio Inc
Shanghai Fosun Pharmaceutical
Sichuan Kelun Pharmaceutical
Shanghai Shyndec Pharmaceutical
CSPC Pharmaceutical Group
United Laboratories International Holdings
Tonghua Dongbao Pharmaceutical
Joincare Pharmaceutical Group
North China Pharma
Anhui Anke Biotechnology
Gan and Lee Pharmaceuticals
Shandong Kexing Bioproducts
Harbin Pharmaceutical Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Fermentation Engineering for Pharmaceutical Drugs, market overview.
Chapter 2: Global Fermentation Engineering for Pharmaceutical Drugs market size in revenue.
Chapter 3: Detailed analysis of Fermentation Engineering for Pharmaceutical Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Fermentation Engineering for Pharmaceutical Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Fermentation Engineering for Pharmaceutical Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Fermentation Engineering for Pharmaceutical Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Fermentation Engineering for Pharmaceutical Drugs Overall Market Size
2.1 Global Fermentation Engineering for Pharmaceutical Drugs Market Size: 2022 VS 2029
2.2 Global Fermentation Engineering for Pharmaceutical Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Fermentation Engineering for Pharmaceutical Drugs Players in Global Market
3.2 Top Global Fermentation Engineering for Pharmaceutical Drugs Companies Ranked by Revenue
3.3 Global Fermentation Engineering for Pharmaceutical Drugs Revenue by Companies
3.4 Top 3 and Top 5 Fermentation Engineering for Pharmaceutical Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Fermentation Engineering for Pharmaceutical Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fermentation Engineering for Pharmaceutical Drugs Players in Global Market
3.6.1 List of Global Tier 1 Fermentation Engineering for Pharmaceutical Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Fermentation Engineering for Pharmaceutical Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Fermentation Engineering for Pharmaceutical Drugs Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Antibiotic
4.1.4 Insulin
4.1.5 Human Growth Hormone
4.1.6 Pharmaceutical Amino Acids
4.1.7 Others
4.2 By Type – Global Fermentation Engineering for Pharmaceutical Drugs Revenue & Forecasts
4.2.1 By Type – Global Fermentation Engineering for Pharmaceutical Drugs Revenue, 2018-2023
4.2.2 By Type – Global Fermentation Engineering for Pharmaceutical Drugs Revenue, 2024-2029
4.2.3 By Type – Global Fermentation Engineering for Pharmaceutical Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Fermentation Engineering for Pharmaceutical Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Fermentation Engineering for Pharmaceutical Drugs Revenue & Forecasts
5.2.1 By Application – Global Fermentation Engineering for Pharmaceutical Drugs Revenue, 2018-2023
5.2.2 By Application – Global Fermentation Engineering for Pharmaceutical Drugs Revenue, 2024-2029
5.2.3 By Application – Global Fermentation Engineering for Pharmaceutical Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Fermentation Engineering for Pharmaceutical Drugs Market Size, 2022 & 2029
6.2 By Region – Global Fermentation Engineering for Pharmaceutical Drugs Revenue & Forecasts
6.2.1 By Region – Global Fermentation Engineering for Pharmaceutical Drugs Revenue, 2018-2023
6.2.2 By Region – Global Fermentation Engineering for Pharmaceutical Drugs Revenue, 2024-2029
6.2.3 By Region – Global Fermentation Engineering for Pharmaceutical Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Fermentation Engineering for Pharmaceutical Drugs Revenue, 2018-2029
6.3.2 US Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.3.3 Canada Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.3.4 Mexico Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Fermentation Engineering for Pharmaceutical Drugs Revenue, 2018-2029
6.4.2 Germany Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.4.3 France Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.4.4 U.K. Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.4.5 Italy Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.4.6 Russia Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.4.8 Benelux Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Fermentation Engineering for Pharmaceutical Drugs Revenue, 2018-2029
6.5.2 China Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.5.3 Japan Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.5.4 South Korea Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.5.6 India Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Fermentation Engineering for Pharmaceutical Drugs Revenue, 2018-2029
6.6.2 Brazil Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.6.3 Argentina Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Fermentation Engineering for Pharmaceutical Drugs Revenue, 2018-2029
6.7.2 Turkey Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.7.3 Israel Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
6.7.5 UAE Fermentation Engineering for Pharmaceutical Drugs Market Size, 2018-2029
7 Fermentation Engineering for Pharmaceutical Drugs Companies Profiles
7.1 Changchun GeneScience Pharmaceutical
7.1.1 Changchun GeneScience Pharmaceutical Company Summary
7.1.2 Changchun GeneScience Pharmaceutical Business Overview
7.1.3 Changchun GeneScience Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Major Product Offerings
7.1.4 Changchun GeneScience Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Revenue in Global Market (2018-2023)
7.1.5 Changchun GeneScience Pharmaceutical Key News & Latest Developments
7.2 3SBio Inc
7.2.1 3SBio Inc Company Summary
7.2.2 3SBio Inc Business Overview
7.2.3 3SBio Inc Fermentation Engineering for Pharmaceutical Drugs Major Product Offerings
7.2.4 3SBio Inc Fermentation Engineering for Pharmaceutical Drugs Revenue in Global Market (2018-2023)
7.2.5 3SBio Inc Key News & Latest Developments
7.3 Shanghai Fosun Pharmaceutical
7.3.1 Shanghai Fosun Pharmaceutical Company Summary
7.3.2 Shanghai Fosun Pharmaceutical Business Overview
7.3.3 Shanghai Fosun Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Major Product Offerings
7.3.4 Shanghai Fosun Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Revenue in Global Market (2018-2023)
7.3.5 Shanghai Fosun Pharmaceutical Key News & Latest Developments
7.4 Sichuan Kelun Pharmaceutical
7.4.1 Sichuan Kelun Pharmaceutical Company Summary
7.4.2 Sichuan Kelun Pharmaceutical Business Overview
7.4.3 Sichuan Kelun Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Major Product Offerings
7.4.4 Sichuan Kelun Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Revenue in Global Market (2018-2023)
7.4.5 Sichuan Kelun Pharmaceutical Key News & Latest Developments
7.5 Shanghai Shyndec Pharmaceutical
7.5.1 Shanghai Shyndec Pharmaceutical Company Summary
7.5.2 Shanghai Shyndec Pharmaceutical Business Overview
7.5.3 Shanghai Shyndec Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Major Product Offerings
7.5.4 Shanghai Shyndec Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Revenue in Global Market (2018-2023)
7.5.5 Shanghai Shyndec Pharmaceutical Key News & Latest Developments
7.6 CSPC Pharmaceutical Group
7.6.1 CSPC Pharmaceutical Group Company Summary
7.6.2 CSPC Pharmaceutical Group Business Overview
7.6.3 CSPC Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Major Product Offerings
7.6.4 CSPC Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Revenue in Global Market (2018-2023)
7.6.5 CSPC Pharmaceutical Group Key News & Latest Developments
7.7 United Laboratories International Holdings
7.7.1 United Laboratories International Holdings Company Summary
7.7.2 United Laboratories International Holdings Business Overview
7.7.3 United Laboratories International Holdings Fermentation Engineering for Pharmaceutical Drugs Major Product Offerings
7.7.4 United Laboratories International Holdings Fermentation Engineering for Pharmaceutical Drugs Revenue in Global Market (2018-2023)
7.7.5 United Laboratories International Holdings Key News & Latest Developments
7.8 Tonghua Dongbao Pharmaceutical
7.8.1 Tonghua Dongbao Pharmaceutical Company Summary
7.8.2 Tonghua Dongbao Pharmaceutical Business Overview
7.8.3 Tonghua Dongbao Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Major Product Offerings
7.8.4 Tonghua Dongbao Pharmaceutical Fermentation Engineering for Pharmaceutical Drugs Revenue in Global Market (2018-2023)
7.8.5 Tonghua Dongbao Pharmaceutical Key News & Latest Developments
7.9 Joincare Pharmaceutical Group
7.9.1 Joincare Pharmaceutical Group Company Summary
7.9.2 Joincare Pharmaceutical Group Business Overview
7.9.3 Joincare Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Major Product Offerings
7.9.4 Joincare Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Revenue in Global Market (2018-2023)
7.9.5 Joincare Pharmaceutical Group Key News & Latest Developments
7.10 North China Pharma
7.10.1 North China Pharma Company Summary
7.10.2 North China Pharma Business Overview
7.10.3 North China Pharma Fermentation Engineering for Pharmaceutical Drugs Major Product Offerings
7.10.4 North China Pharma Fermentation Engineering for Pharmaceutical Drugs Revenue in Global Market (2018-2023)
7.10.5 North China Pharma Key News & Latest Developments
7.11 Anhui Anke Biotechnology
7.11.1 Anhui Anke Biotechnology Company Summary
7.11.2 Anhui Anke Biotechnology Business Overview
7.11.3 Anhui Anke Biotechnology Fermentation Engineering for Pharmaceutical Drugs Major Product Offerings
7.11.4 Anhui Anke Biotechnology Fermentation Engineering for Pharmaceutical Drugs Revenue in Global Market (2018-2023)
7.11.5 Anhui Anke Biotechnology Key News & Latest Developments
7.12 Gan and Lee Pharmaceuticals
7.12.1 Gan and Lee Pharmaceuticals Company Summary
7.12.2 Gan and Lee Pharmaceuticals Business Overview
7.12.3 Gan and Lee Pharmaceuticals Fermentation Engineering for Pharmaceutical Drugs Major Product Offerings
7.12.4 Gan and Lee Pharmaceuticals Fermentation Engineering for Pharmaceutical Drugs Revenue in Global Market (2018-2023)
7.12.5 Gan and Lee Pharmaceuticals Key News & Latest Developments
7.13 Shandong Kexing Bioproducts
7.13.1 Shandong Kexing Bioproducts Company Summary
7.13.2 Shandong Kexing Bioproducts Business Overview
7.13.3 Shandong Kexing Bioproducts Fermentation Engineering for Pharmaceutical Drugs Major Product Offerings
7.13.4 Shandong Kexing Bioproducts Fermentation Engineering for Pharmaceutical Drugs Revenue in Global Market (2018-2023)
7.13.5 Shandong Kexing Bioproducts Key News & Latest Developments
7.14 Harbin Pharmaceutical Group
7.14.1 Harbin Pharmaceutical Group Company Summary
7.14.2 Harbin Pharmaceutical Group Business Overview
7.14.3 Harbin Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Major Product Offerings
7.14.4 Harbin Pharmaceutical Group Fermentation Engineering for Pharmaceutical Drugs Revenue in Global Market (2018-2023)
7.14.5 Harbin Pharmaceutical Group Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer